Nektar Therapeutics (NKTR)
NASDAQ·Healthcare·Biotechnology
$83.59
-3.63%
Mkt Cap $1.85B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | $10.19M | $21.81M | +114.01% | -$2.76 | -$1.78 | +35.51% | — | — |
| Q4 2025 Nov 6, 2025 | $10.44M | $11.79M | +12.94% | -$2.85 | -$1.85 | +35.09% | — | — |
| Q3 2025 Aug 7, 2025 | $9.42M | $11.18M | +18.68% | -$3.13 | -$2.95 | +5.75% | — | — |
| Q2 2025 May 8, 2025 | $15.36M | $10.46M | -31.88% | -$2.70 | -$3.30 | -22.22% | — | — |
| Q1 2025 Mar 12, 2025 | $36.66M | $29.18M | -20.41% | -$1.95 | -$2.25 | -15.38% | — | — |
| Q4 2024 Nov 7, 2024 | $31.39M | $24.12M | -23.15% | -$0.23 | -$0.18 | +21.74% | — | — |
| Q3 2024 Aug 8, 2024 | $17.54M | $23.49M | +33.92% | -$0.21 | -$0.25 | -19.05% | — | — |
| Q2 2024 May 9, 2024 | $15.34M | $21.64M | +41.06% | -$0.21 | -$0.18 | +14.29% | — | — |
| Q1 2024 Mar 4, 2024 | $18.05M | $23.89M | +32.33% | -$0.20 | -$0.22 | -10.00% | — | — |
| Q4 2023 Nov 7, 2023 | $18.62M | $24.14M | +29.67% | -$0.18 | -$0.19 | -5.56% | — | — |
| Q3 2023 Aug 8, 2023 | $21.79M | $20.50M | -5.92% | -$0.30 | -$0.27 | +10.00% | — | — |
| Q2 2023 May 9, 2023 | $20.58M | $21.59M | +4.93% | -$0.26 | -$0.25 | +3.85% | — | — |
| Q1 2023 Feb 28, 2023 | $22.14M | $22.02M | -0.51% | -$0.45 | -$0.32 | +28.89% | — | — |
| Q4 2022 Nov 3, 2022 | $22.61M | $23.63M | +4.50% | -$0.47 | -$0.24 | +48.94% | — | — |
| Q3 2022 Aug 4, 2022 | $22.62M | $21.59M | -4.56% | -$1.01 | -$0.85 | +15.84% | — | — |
| Q2 2022 May 5, 2022 | $24.30M | $24.82M | +2.16% | -$0.72 | -$0.49 | +31.94% | — | — |
| Q1 2022 Feb 28, 2022 | $34.26M | $25.01M | -27.01% | -$0.81 | -$0.79 | +2.47% | — | — |
| Q4 2021 Nov 4, 2021 | $27.82M | $24.92M | -10.42% | -$0.80 | -$0.70 | +12.50% | — | — |
| Q3 2021 Aug 5, 2021 | $25.98M | $28.33M | +9.05% | -$0.72 | -$0.69 | +4.17% | — | — |
| Q2 2021 May 6, 2021 | $27.19M | $23.65M | -13.03% | -$0.72 | -$0.68 | +5.56% | — | — |